Ariane Herrick

Summary

Affiliation: University of Manchester
Country: UK

Publications

  1. pmc A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis
    Lara Bossini-Castillo
    Instituto de Parasitologia y Biomedicina Lopez Neyra, IPBLN CSIC, Avenida del Conocimiento s n, Granada, 18100, Spain
    Arthritis Res Ther 14:R85. 2012
  2. doi request reprint Management of Raynaud's phenomenon and digital ischemia
    Ariane L Herrick
    Centre for Musculoskeletal Research, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, University of Manchester, Salford M6 8HD, UK
    Curr Rheumatol Rep 15:303. 2013
  3. doi request reprint Acro-osteolysis in systemic sclerosis is associated with digital ischaemia and severe calcinosis
    Emma M Johnstone
    University of Manchester, Manchester Academic Health Science Centre, Salford Royal Hospital, Salford, UK
    Rheumatology (Oxford) 51:2234-8. 2012
  4. doi request reprint The pathogenesis, diagnosis and treatment of Raynaud phenomenon
    Ariane L Herrick
    University of Manchester, Manchester Academic Health Science Centre, Salford Royal Hospital, Salford M6 8HD, UK
    Nat Rev Rheumatol 8:469-79. 2012
  5. pmc Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocol
    Begonya Alcacer-Pitarch
    Division of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK
    BMC Musculoskelet Disord 13:11. 2012
  6. doi request reprint Contemporary management of Raynaud's phenomenon and digital ischaemic complications
    Ariane L Herrick
    The University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK
    Curr Opin Rheumatol 23:555-61. 2011
  7. doi request reprint Clinical features of childhood localized scleroderma in an incidence cohort
    Ariane L Herrick
    Arthritis Research UK Epidemiology Unit, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK
    Rheumatology (Oxford) 50:1865-8. 2011
  8. doi request reprint Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis
    Ariane L Herrick
    University of Manchester, Manchester Academic Health Science Centre, Salford Royal Hospital, Salford, UK
    Arthritis Rheum 63:775-82. 2011
  9. doi request reprint Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia
    Ariane L Herrick
    The University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK
    Rheumatology (Oxford) 49:1776-82. 2010
  10. doi request reprint Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland
    Ariane L Herrick
    University of Manchester, Manchester, UK, and Salford Royal Hospital, Salford, UK
    Arthritis Care Res (Hoboken) 62:213-8. 2010

Collaborators

  • Holly Ennis
  • Christopher P Denton
  • Alan J Silman
  • Michael Hughes
  • Armando Gabrielli
  • Frank A Wollheim
  • Murray Baron
  • DANIEL ERIC FURST
  • Janet Pope
  • J H Korn
  • Peter Merkel
  • Bashar Kahaleh
  • MAUREEN MAUREEN MAYES
  • D Khanna
  • Lara Bossini-Castillo
  • Begonya Alcacer-Pitarch
  • Emma M Johnstone
  • Tonia L Moore
  • Paul Emery
  • Hashim Gazi
  • Sylvia Casari
  • Javier Martin
  • Alexander Kreuter
  • Roger Hesselstrand
  • Timothy Rdj Radstake
  • Lorenzo Beretta
  • Jonathan Wright
  • Heidi J Siddle
  • Claudio Lunardi
  • Javier Narvaez
  • Annemie J Schuerwegh
  • Maya H Buch
  • Torsten Witte
  • Anthony C Redmond
  • Maria T Camps
  • Aurelie Chevance
  • Carlos Tolosa
  • Gerard Espinosa
  • Charles E Hutchinson
  • Jacob M van Laar
  • Philip S Helliwell
  • Nuria Navarro-Coy
  • Andy Vail
  • María del Carmen Freire
  • Carmen P Simeon
  • Miguel A Gonzalez-Gay
  • Meng May Chee
  • Carmen Fonseca
  • Jasper C Broen
  • Maria J Castillo
  • Patricia Carreira
  • Sue Pavitt
  • Bobby Pc Koeleman
  • Howard Collier
  • Raquel Ríos-Fernández
  • Anna Maria Hoffmann-Vold
  • Lorraine Loughrey
  • Janine Gray
  • Madelon C Vonk
  • Emma Beltran
  • Christopher Roberts
  • Andrea K Murray
  • Ingrid Helbling
  • Richard W Martin
  • Philip Clements
  • Naomi F Rothfield
  • Thomas Krieg
  • Larry W Moreland
  • Thomas A Medsger
  • Mary Ellen Csuka
  • Carol Black
  • Edward V Lally
  • Jill F Belch
  • Pius Bruehlmann
  • Kevin M McKown
  • Alexander E Voskuyl
  • James R Siebold
  • Michael H Ellman
  • Murat Inanc
  • Laszlo Czirjak
  • Samina Hayat
  • Vivien Hsu
  • Mansel Haeney
  • Sue Farrand

Detail Information

Publications19

  1. pmc A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis
    Lara Bossini-Castillo
    Instituto de Parasitologia y Biomedicina Lopez Neyra, IPBLN CSIC, Avenida del Conocimiento s n, Granada, 18100, Spain
    Arthritis Res Ther 14:R85. 2012
    ..The aim of this study was to test the influence of CD226 loci in SSc susceptibility, clinical phenotypes and autoantibody status in a large multicenter European population...
  2. doi request reprint Management of Raynaud's phenomenon and digital ischemia
    Ariane L Herrick
    Centre for Musculoskeletal Research, Institute of Inflammation and Repair, University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, University of Manchester, Salford M6 8HD, UK
    Curr Rheumatol Rep 15:303. 2013
    ..Increased availability and interest in nailfold capillaroscopy, by facilitating early diagnosis of SSc, should pave the way for studies of early intervention and vascular protection...
  3. doi request reprint Acro-osteolysis in systemic sclerosis is associated with digital ischaemia and severe calcinosis
    Emma M Johnstone
    University of Manchester, Manchester Academic Health Science Centre, Salford Royal Hospital, Salford, UK
    Rheumatology (Oxford) 51:2234-8. 2012
    ..Our aim was to investigate the hypothesis that acro-osteolysis is associated with (i) the severity of digital ischaemia and (ii) the presence of calcinosis...
  4. doi request reprint The pathogenesis, diagnosis and treatment of Raynaud phenomenon
    Ariane L Herrick
    University of Manchester, Manchester Academic Health Science Centre, Salford Royal Hospital, Salford M6 8HD, UK
    Nat Rev Rheumatol 8:469-79. 2012
    ..This Review provides an update of the pathogenesis, diagnosis and treatment of Raynaud phenomenon. Current and future treatment approaches are discussed, and some key unanswered questions are highlighted...
  5. pmc Pressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocol
    Begonya Alcacer-Pitarch
    Division of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, UK
    BMC Musculoskelet Disord 13:11. 2012
    ..The primary aim of this trial is to evaluate whether foot pain and foot-related health status in people with Systemic Sclerosis can be improved through the provision of a simple pressure-relieving insole...
  6. doi request reprint Contemporary management of Raynaud's phenomenon and digital ischaemic complications
    Ariane L Herrick
    The University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK
    Curr Opin Rheumatol 23:555-61. 2011
    ..New approaches to therapy are being driven by increased understanding of pathophysiology and by increased international networking of clinicians and scientists, facilitating clinical trials...
  7. doi request reprint Clinical features of childhood localized scleroderma in an incidence cohort
    Ariane L Herrick
    Arthritis Research UK Epidemiology Unit, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK
    Rheumatology (Oxford) 50:1865-8. 2011
    ..Our aim was to describe clinical features and pattern of care in children with localized scleroderma presenting to secondary care during a 25-month incidence study...
  8. doi request reprint Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis
    Ariane L Herrick
    University of Manchester, Manchester Academic Health Science Centre, Salford Royal Hospital, Salford, UK
    Arthritis Rheum 63:775-82. 2011
    ..To examine the effect of sildenafil in patients with Raynaud's phenomenon (RP) secondary to limited cutaneous systemic sclerosis (lcSSc)...
  9. doi request reprint Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia
    Ariane L Herrick
    The University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK
    Rheumatology (Oxford) 49:1776-82. 2010
    ..v. vasodilators, debridements or amputations), (ii) a positive ACA, (iii) clinically evident calcinosis, (iv) pulmonary arterial hypertension and (v) telangiectases...
  10. doi request reprint Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland
    Ariane L Herrick
    University of Manchester, Manchester, UK, and Salford Royal Hospital, Salford, UK
    Arthritis Care Res (Hoboken) 62:213-8. 2010
    ..Our aim was to ascertain the incidence of childhood scleroderma in its different forms in the UK and Ireland, and to describe the age, sex, and ethnicity of the cases...
  11. doi request reprint Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis
    Ariane L Herrick
    ARC Epidemiology Unit, Stopford Building, University of Manchester, Manchester M13 9PL, United Kingdom
    J Rheumatol 37:116-24. 2010
    ..We used an observational approach to estimate the relative effectiveness of different current treatment approaches, capturing entry and outcome data in a standardized way...
  12. doi request reprint Therapy: A local approach to Raynaud phenomenon
    Ariane L Herrick
    University of Manchester and Salford Royal Hospital, Salford, Manchester, UK
    Nat Rev Rheumatol 5:246-7. 2009
    ..Topical, or transdermal, treatments that increase digital blood flow without systemic adverse effects are, therefore, an attractive option. A novel topical nitroglycerin formulation has shown promise in treating Raynaud attacks...
  13. doi request reprint Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis
    Ariane L Herrick
    University of Manchester, Manchester, UK, and Salford Royal National Health Service Foundation Trust, Salford, UK
    Arthritis Rheum 60:878-82. 2009
    ..To test the intra- and interobserver variability, among clinicians with an interest in systemic sclerosis (SSc), in defining digital ulcers...
  14. doi request reprint Diagnosis and management of scleroderma peripheral vascular disease
    Ariane Herrick
    Rheumatic Diseases Centre, University of Manchester, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK
    Rheum Dis Clin North Am 34:89-114; vii. 2008
    ..New vasoactive treatments are currently being researched and older treatments revisited; therefore new approaches to therapy will likely be developed over the next 5 to 10 years...
  15. ncbi request reprint Systemic sclerosis
    Michael Hughes
    Department of Rheumatology, Salford Royal Hospital, Salford, UK
    Br J Hosp Med (Lond) 73:509-10, 511-6. 2012
    ..This review updates the clinician on the pathogenesis, differential diagnosis and spectrum of disease in systemic sclerosis. The wide range of current therapeutic options and future targeted molecular therapies are also explored...
  16. doi request reprint Reliability of dermoscopy in the assessment of patients with Raynaud's phenomenon
    Tonia L Moore
    Salford Royal NHS Foundation Trust, Salford M6 8HD, UK
    Rheumatology (Oxford) 49:542-7. 2010
    ..Good reliability is a necessary prerequisite for a test to be a valid clinical or research tool...
  17. ncbi request reprint Outcome measurements in scleroderma: results from a delphi exercise
    Hashim Gazi
    Division of Rheumatology, Department of Medicine, The University of Western Ontario, London, Ontario, Canada
    J Rheumatol 34:501-9. 2007
    ..To obtain a consensus on the minimal clinically relevant treatment effect in various scleroderma disease outcome measures to be used in future clinical trials...
  18. doi request reprint Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial
    Peter A Merkel
    Boston University School of Medicine, Boston, MA 02118, USA
    Arthritis Rheum 59:699-705. 2008
    ..To determine the validity, reliability, and feasibility of durometer measurements of skin hardness as an outcome measure in clinical trials of scleroderma...
  19. ncbi request reprint Antineutrophil cytoplasmic antibodies a "Red Flag" in patients with systemic sclerosis
    Sylvia Casari
    J Rheumatol 29:2666-7. 2002